Geri
VISEN Pharmaceuticals (02561.HK) Fiyatı
02561.HK Hisse Senedi Fiyat Grafiği
VISEN PHARMA-B (02561.HK)
VISEN Pharmaceuticals
HK$33.8
-1.51%
$-0.52
Piyasa Kapalı: Jan 16, 16:00:00 HKT
Önemli İstatistikler
Önceki Kapanış
$34.42
Açılış fiyatı
$34.32
Günün Aralığı
$33.1 - $34.32
52 haftalık aralık
$29.06 - $69.15
İşlem hacmi
15.6K
Ort.Hacim
32.8K
EPS (TTM)
-2.12
Dividend yield
--
Piyasa Değeri
$3.8B
VISEN PHARMA-B nedir?
VISEN Pharmaceuticals operates as a biopharmaceutical company. The company is headquartered in Suzhou, Jiangsu and currently employs 54 full-time employees. The company went IPO on 2025-03-21. The firm's main products under development include lonapegsomatropin, navepegritide, and palopegteriparatide. The lonapegsomatropin is used to treat growth hormone deficiency in children aged 3 to 17 years old. The navepegritide is a disease repair therapy used to treat children with cartilage dysplasia aged 2 to 10 years old. The palopegteriparatide is a treatment method used to treat adult hypoparathyroidism. The firm is in the late stage of research and development, and its products are close to commercialization.
Özellikler
Ticaret Stratejileri
Kaynaklar
© 2025 Finture Development Limited. All rights reserved
